Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 236186, 10 pages
http://dx.doi.org/10.1093/ecam/neq038
Original Article

Bacopa monniera Attenuates Scopolamine-Induced Impairment of Spatial Memory in Mice

1Department of Neurology, Post Graduate Institute of Medical Education and Research, Sector-12, Chandigarh 160012, India
2Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA
3Department of Biophysics, Post Graduate Institute of Medical Education and Research, Chandigarh, India

Received 31 August 2009; Accepted 31 March 2010

Copyright © 2011 Manish Kumar Saraf et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Basu and S. K. Bhattacharya, “Dementia current status,” Postgraduate Medicine, vol. 17, pp. 543–551, 2003. View at Google Scholar
  2. U. Ebert and W. Kirch, “Scopolamine model of dementia: electroencephalogram findings and cognitive performance,” European Journal of Clinical Investigation, vol. 28, no. 11, pp. 944–949, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. S. V. Ovsepian, R. Anwyl, and M. J. Rowan, “Endogenous acetylcholine lowers the threshold for long-term potentiation induction in the CA1 area through muscarinic receptor activation: in vivo study,” European Journal of Neuroscience, vol. 20, pp. 1267–1275, 2004. View at Google Scholar
  4. J. M. M. Gijtenbeek, M. J. Van Den Bent, and C. J. Vecht, “Cyclosporine neurotoxicity: a review,” Journal of Neurology, vol. 246, no. 5, pp. 339–346, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. W. C. Johnson and O. W. William, “Warfarin toxicity,” Journal of Vascular Surgery, vol. 35, pp. 413–431, 2002. View at Google Scholar
  6. W.H.O., Traditional Medicine, Fact Sheet, no. 134, World Health Organization, Geneva, Switzerland, 2003.
  7. M.-J. R. Howes and P. J. Houghton, “Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function,” Pharmacology Biochemistry and Behavior, vol. 75, no. 3, pp. 513–527, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. M. J. Howes, N. S. Perry, and P. J. Houghton, “Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders,” Phytotherapy Research, vol. 17, pp. 1–18, 2003. View at Google Scholar
  9. T. Tully, R. Bourtchouladze, R. Scott, and J. Tallman, “Targeting the creb pathway for memory enhancers,” Nature Reviews Drug Discovery, vol. 2, no. 4, pp. 267–277, 2003. View at Google Scholar · View at Scopus
  10. A. Clegg, J. Bryant, T. Nicholson et al., “Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease: a systematic review,” International Journal of Technology Assessment in Health Care, vol. 18, no. 3, pp. 497–507, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. K. G. Mohandas Rao, S. Muddanna Rao, and S. Gurumadhva Rao, “Enhancement of amygdaloid neuronal dendritic arborization by fresh leaf juice of Centella asiatica (Linn) during growth spurt period in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 6, no. 2, pp. 203–210, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. K. G. Mohandas Rao, S. Muddanna Rao, and S. Gurumadhva Rao, “Centella asiatica (L.) leaf extract treatment during the growth spurt period enhances hippocampal CA3 neuronal dendritic arborization in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 3, pp. 349–357, 2006. View at Google Scholar
  13. H. Joshi and M. Parle, “Brahmi rasayana improves learning and memory in mice,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 1, pp. 79–85, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Chatterji, R. P. Rastogi, and M. L. Dhar, “Chemical examination of Bacopa monniera Wettst—part II: the constitution of Bacoside A,” Indian Journal of Chemistry, vol. 3, pp. 24–29, 1965. View at Google Scholar
  15. H. K. Singh and B. N. Dhawan, “Effect of Bacopa monniera Linn. (Brahmi) extract on avoidance responses in rat,” Journal of Ethnopharmacology, vol. 5, no. 2, pp. 205–214, 1982. View at Google Scholar · View at Scopus
  16. D. Vohora, S. N. Pal, and K. K. Pillai, “Protection from phenytoin-induced cognitive deficit by Bacopa monniera, a reputed Indian nootropic plant,” Journal of Ethnopharmacology, vol. 71, no. 3, pp. 383–390, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Russo and F. Borrelli, “Bacopa monniera, a reputed nootropic plant: an overview,” Phytomedicine, vol. 12, no. 4, pp. 305–317, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. B. N. Dhawan and H. K. Singh, “Pharmacology of ayurvedicnootropic Bacopa monniera,” in Proceedings of the International Convention of Biological Psychiatry, Bombay, India, 1996, abstract no. NR 59.
  19. K. Anbarasi, G. Vani, K. Balakrishna, and C. S. S. Devi, “Effect of bacoside A on brain antioxidant status in cigarette smoke exposed rats,” Life Sciences, vol. 78, no. 12, pp. 1378–1384, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Das, G. Shanker, C. Nath, R. Pal, S. Singh, and H. K. Singh, “A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba—anticholinesterase and cognitive enhancing activities,” Pharmacology Biochemistry and Behavior, vol. 73, no. 4, pp. 893–900, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Kishore and M. Singh, “Effect of bacosides, alcoholic extract of Bacopa monniera Linn. (brahmi), on experimental amnesia in mice,” Indian Journal of Experimental Biology, vol. 43, no. 7, pp. 640–645, 2005. View at Google Scholar · View at Scopus
  22. P. J. Nathan, S. Tanner, J. Lloyd et al., “Effects of a combined extract of Ginkgo biloba and Bacopa monniera on cognitive function in healthy humans,” Human Psychopharmacology, vol. 19, no. 2, pp. 91–96, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Dhanasekaran, B. Tharakan, L. A. Holcomb, A. R. Hitt, K. A. Young, and B. V. Manyam, “Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monniera,” Phytotherapy Research, vol. 21, no. 10, pp. 965–969, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. L. A. Holcomb, M. Dhanasekaran, A. R. Hitt, K. A. Young, M. Riggs, and B. V. Manyam, “Bacopa monniera extract reduces amyloid levels in PSAPP mice,” Journal of Alzheimer's Disease, vol. 9, no. 3, pp. 243–251, 2006. View at Google Scholar · View at Scopus
  25. K. Anbarasi, G. Kathirvel, G. Vani, G. Jayaraman, and C. S. Shyamala Devi, “Cigarette smoking induces heat shock protein 70 kDa expression and apoptosis in rat brain: modulation by bacoside A,” Neuroscience, vol. 138, no. 4, pp. 1127–1135, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. K. Bhattacharya, A. Bhattacharya, A. Kumar, and S. Ghosal, “Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus,” Phytotherapy Research, vol. 14, no. 3, pp. 174–179, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. R. H. Singh and R. L. Singh, “Studies on the antioxidant anxiety effect of the Medhay Rasayan drug Brahmi (Bacopa monniera Linn)—part II (experimental studies),” Journal of Research in Indian Medicine, Yoga and Homeopathy, vol. 14, pp. 1–6, 1980. View at Google Scholar
  28. V. Vijayan and A. Helen, “Protective activity of Bacopa monniera Linn. on nicotine-induced toxicity in mice,” Phytotherapy Research, vol. 21, no. 4, pp. 378–381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Jyoti, P. Sethi, and D. Sharma, “Bacopa monniera prevents from aluminium neurotoxicity in the cerebral cortex of rat brain,” Journal of Ethnopharmacology, vol. 111, no. 1, pp. 56–62, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Raghav, H. Singh, P. K. Dalal, J. S. Shrivastava, and O. P. Asthana, “Randomized controlled trial of standardized Bacopa monniera extract in age-associated memory impairment,” Indian Journal of Psychiatry, vol. 48, pp. 238–242, 2006. View at Google Scholar
  31. C. Calabrese, W. L. Gregory, M. Leo, D. Kraemer, K. Bone, and B. Oken, “Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial,” Journal of Alternative and Complementary Medicine, vol. 14, no. 6, pp. 707–713, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Sharma, C. Chaturvedi, and P. Tewari, “Efficacy of Bacopa monniera in revitalizing intellectual functions in children,” Journal of Research and Education in Indian Medicine, vol. 23, pp. 1–12, 1987. View at Google Scholar
  33. K. S. Negi, Y. D. Singh, K. P. Kushwaha et al., “Clinical evaluation of memory enhancing properties of Memory Plus in children with attention deficit hyperactivity disorder,” Indian Journal of Psychiatry, vol. 42, 2000. View at Google Scholar
  34. G. Benzi and A. Moretti, “Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?” European Journal of Pharmacology, vol. 346, pp. 1–13, 1998. View at Google Scholar
  35. R. Morris, “Developments of a water-maze procedure for studying spatial learning in the rat,” Journal of Neuroscience Methods, vol. 11, no. 1, pp. 47–60, 1984. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Prabhakar, M. K. Saraf, P. Pandhi, and A. Anand, “Bacopa monniera exerts antiamnesic effect on diazepam-induced anterograde amnesia in mice,” Psychopharmacology, vol. 200, no. 1, pp. 27–37, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. H. G. Vogel, “Drug effects on learning and memory,” in Drug Discovery and Evaluation: Pharmacological Assays, W. H. Vogel, B. A. Schlkens, J. Sandow et al., Eds., pp. 595–643, Springer, Berlin, Germany, 2nd edition, 2002. View at Google Scholar
  38. D. S. Olton, A. Markowska, S. J. Breckler, G. L. Wenk, K. C. Pang, and V. Koliatsos, “Individual differences in aging: behavioral and neural analyses,” Biomedical and Environmental Sciences, vol. 4, no. 1-2, pp. 166–172, 1991. View at Google Scholar · View at Scopus
  39. D. Olton, A. Markowska, M. L. Voytko, B. Givens, L. Gorman, and G. Wenk, “Basal forebrain cholinergic system: a functional analysis,” Advances in Experimental Medicine and Biology, vol. 295, pp. 353–372, 1991. View at Google Scholar · View at Scopus
  40. J. Watts, R. Stevens, and C. Robinson, “Effects of scopolamine on radial maze performance in rats,” Physiology and Behavior, vol. 26, no. 5, pp. 845–851, 1981. View at Publisher · View at Google Scholar · View at Scopus
  41. S. G. Anagnostaras, S. Maren, and M. S. Fanselow, “Scopolamine selectively disrupts the acquisition of contextual fear conditioning in rats,” Neurobiology of Learning and Memory, vol. 64, no. 3, pp. 191–194, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Sakata, R. Chida, K. Ishige, Y. Edagawa, T. Tadano, and Y. Ito, “Effect of a nutritive-tonic drink on scopolamine-induced memory impairment in mice,” Biological and Pharmaceutical Bulletin, vol. 28, no. 10, pp. 1886–1891, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Naghdi, M. Rezaei, and Y. Fathollahi, “Microinjection of ritanserin into the CA1 region of hippocampus improves scopolamine-induced amnesia in adult male rats,” Behavioural Brain Research, vol. 168, no. 2, pp. 215–220, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Z. Mintzer and R. R. Griffiths, “Drugs, memory, and metamemory: a dose-effect study with lorazepam and scopolamine,” Experimental and Clinical Psychopharmacology, vol. 13, no. 4, pp. 336–347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Meziane, J.-C. Dodart, C. Mathis et al., “Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 21, pp. 12683–12688, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Ennaceur and K. Meliani, “Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests,” Psychopharmacology, vol. 109, no. 3, pp. 321–330, 1992. View at Publisher · View at Google Scholar · View at Scopus
  47. N. M. J. Rupniak, M. J. Field, N. A. Samson, M. J. Steventon, and S. D. Iversen, “Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models,” Neurobiology of Aging, vol. 11, no. 6, pp. 609–613, 1990. View at Publisher · View at Google Scholar · View at Scopus
  48. A. J. Jalkanen, K. A. Puttonen, J. I. Venäläinen et al., “Beneficial effect of prolyl oligopeptidase inhibition on spatial memory in young but not in old scopolamine-treated rats,” Basic and Clinical Pharmacology and Toxicology, vol. 100, no. 2, pp. 132–138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. D. H. Kim, S. J. Jeon, K. H. Son et al., “The ameliorating effect of oroxylin A on scopolamine-induced memory impairment in mice,” Neurobiology of Learning and Memory, vol. 87, no. 4, pp. 536–546, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Yen, M. S. Roberson, S. Varvayanis, and A. T. Lee, “Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest,” Cancer Research, vol. 58, pp. 3163–3172, 1998. View at Google Scholar
  51. N. Naghdi, M. Rezaei, and Y. Fathollahi, “Microinjection of ritanserin into the CA1 region of hippocampus improves scopolamine-induced amnesia in adult male rats,” Behavioural Brain Research, vol. 168, no. 2, pp. 215–220, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. D. H. Kim, T. M. Hung, K. H. Bae et al., “Gomisin A improves scopolamine-induced memory impairment in mice,” European Journal of Pharmacology, vol. 542, no. 1–3, pp. 129–135, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. N. M. J. Rupniak, N. A. Samson, M. J. Steventon, and S. D. Iversen, “Induction of cognitive impairment by scopolamine and noncholinergic agents in rhesus monkeys,” Life Sciences, vol. 48, no. 9, pp. 893–899, 1991. View at Publisher · View at Google Scholar · View at Scopus
  54. M. M. Ghoneim and S. P. Mewaldt, “Studies on human memory: the interactions of diazepam, scopolamine, and physostigmine,” Psychopharmacology, vol. 52, no. 1, pp. 1–6, 1977. View at Google Scholar · View at Scopus
  55. M. M. Ghoneim and S. P. Mewaldt, “Effects of diazepam and scopolamine on storage, retrieval and organizational processes in memory,” Psychopharmacologia, vol. 44, no. 3, pp. 257–262, 1975. View at Google Scholar · View at Scopus
  56. M. E. Hasselmo, B. P. Wyble, and G. V. Wallenstein, “Encoding and retrieval of episodic memories: role of cholinergic and GABAergic modulation in the hippocampus,” Hippocampus, vol. 6, no. 6, pp. 693–708, 1996. View at Publisher · View at Google Scholar · View at Scopus
  57. S. K. Bhattacharya, A. Kumar, and S. Ghosal, “Effect of Bacopa monniera on animal models of Alzheimer's disease and perturbed central cholinergic markers of cognition in rats,” in Molecular Aspects of Asian Medicines, D. V. Siva Sanka, Ed., pp. 21–32, PJD, New York, NY, USA, 2000. View at Google Scholar
  58. C. Stough, J. Lloyd, J. Clarke et al., “The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects,” Psychopharmacology, vol. 156, no. 4, pp. 481–484, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Roodenrys, D. Booth, S. Bulzomi, A. Phipps, C. Micallef, and J. Smoker, “Chronic effects of Brahmi (Bacopa monnieri) on human memory,” Neuropsychopharmacology, vol. 27, no. 2, pp. 279–281, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. K. B. Siripurapu, P. Gupta, G. Bhatia, R. Maurya, C. Nath, and G. Palit, “Adaptogenic and anti-amnesic properties of Evolvulus alsinoides in rodents,” Pharmacology Biochemistry and Behavior, vol. 81, no. 3, pp. 424–432, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. T. Yamazaki, M. Yaguchi, Y. Nakajima et al., “Effects of an aqueous extract of Puerariae flos (Thomsonide) on impairment of passive avoidance behavior in mice,” Journal of Ethnopharmacology, vol. 100, no. 3, pp. 244–248, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. S.-C. Ho, Y.-F. Ho, T.-H. Lai, T.-H. Liu, and R.-Y. Wu, “Traditional Chinese herbs against hypertension enhance the effect of memory acquisition,” American Journal of Chinese Medicine, vol. 33, no. 5, pp. 787–795, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Y. Bao, J. Zhang, S. J. Yeo et al., “Memory enhancing and neuroprotective effects of selected ginsenosides,” Archives of Pharmacal Research, vol. 28, no. 3, pp. 335–342, 2005. View at Google Scholar · View at Scopus
  64. M. Parle, D. Dhingra, and S. K. Kulkarni, “Memory-strengthening activity of Glycyrrhiza glabra in exteroceptive and interoceptive behavioral models,” Journal of Medicinal Food, vol. 7, no. 4, pp. 462–466, 2004. View at Google Scholar · View at Scopus
  65. Y. Zhou, L. Peng, W.-D. Zhang, and D.-Y. Kong, “Effect of triterpenoid saponins from Bacopa monnieraon scopolamine-induced memory impairment in mice,” Planta Medica, vol. 75, no. 6, pp. 568–574, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. B. Tripathi, S. Chaurasia, E. Tripathi, A. Upadhyay, and G. P. Dubey, “Bacopa monniera Linn. as an antioxidant: mechanism of action,” Indian Journal of Experimental Biology, vol. 34, no. 6, pp. 523–526, 1996. View at Google Scholar · View at Scopus
  67. N. Uabundit, J. Wattanathorn, S. Mucimapura, and K. Ingkaninan, “Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer's disease model,” Journal of Ethnopharmacology, vol. 127, pp. 26–31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Hosamani and Muralidhara, “Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster,” NeuroToxicology, vol. 30, no. 6, pp. 977–985, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. P. Calabresi, D. Centonze, P. Gubellini, A. Pisani, and G. Bernardi, “Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation,” European Journal of Neuroscience, vol. 10, no. 9, pp. 2887–2895, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. S. K. Hota, K. Barhwal, I. Baitharu, D. Prasad, S. B. Singh, and G. Ilavazhagan, “Bacopa monniera leaf extract ameliorates hypobaric hypoxia induced spatial memory impairment,” Neurobiology of Disease, vol. 34, no. 1, pp. 23–39, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. C. S. Paulose, F. Chathu, S. Khan, and A. Krishnakumar, “Neuroprotective role of Bacopa monnieri extract in epilepsy and effect of glucose supplementation during hypoxia: glutamate receptor gene expression,” Neurochemical Research, vol. 33, pp. 1663–1671, 2007. View at Google Scholar
  72. J. Brouillette, D. Young, M. J. During, and R. Quirion, “Hippocampal gene expression profiling reveals the possible involvement of Homer1 and GABAB receptors in scopolamine-induced amnesia,” Journal of Neurochemistry, vol. 102, no. 6, pp. 1978–1989, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. G. Martis, A. Rao, and K. S. Karanth, “Neuropharmacological activity of Herpestis monniera,” Fitoterapia, vol. 63, no. 5, pp. 399–404, 1992. View at Google Scholar · View at Scopus